A complex interplay between H2A.Z and HP1 isoforms regulates pericentric heterochromatin


González J. Bosch-Presegué L. Marazuela-Duque A. Guitart-Solanes A. Espinosa-Alcantud M. Fernandez A.F. Brown J.P. Ausió J. Vazquez B.N. Singh P.B. Fraga M.F. Vaquero A.
2023Frontiers Media SA

Frontiers in Cell and Developmental Biology
2023#11

Pericentric heterochromatin (PCH) plays an essential role in the maintenance of genome integrity and alterations in PCH have been linked to cancer and aging. HP1 α, β, and γ, are hallmarks of constitutive heterochromatin that are thought to promote PCH structure through binding to heterochromatin-specific histone modifications and interaction with a wide range of factors. Among the less understood components of PCH is the histone H2A variant H2A.Z, whose role in the organization and maintenance of PCH is poorly defined. Here we show that there is a complex interplay between H2A.Z and HP1 isoforms in PCH. While the loss of HP1α results in the accumulation of H2A.Z.1 in PCH, which is associated with a significant decrease in its mobile fraction, H2A.Z.1 binds preferentially to HP1β in these regions. Of note, H2A.Z.1 downregulation results in increased heterochromatinization and instability of PCH, reflected by accumulation of the major epigenetic hallmarks of heterochromatin in these regions and increased frequency of chromosome aberrations related to centromeric/pericentromeric defects. Our studies support a role for H2A.Z in genome stability and unveil a key role of H2A.Z in the regulation of heterochromatin-specific epigenetic modifications through a complex interplay with the HP1 isoforms. Copyright

epigenetics , genome stability , H2A.Z , H3K9me3 , H4K20me3 , heterochromatin , HP1α,β,γ

Text of the article Перейти на текст статьи

Chromatin Biology Laboratory, Josep Carreras Leukaemia Research Institute (IJC), Barcelona, Spain
Tissue Repair and Regeneration Laboratory (TR2Lab), Institut de Recerca I Innovació en Ciències de La Vida i de La Salut a La Catalunya Central (IrisCC), Barcelona, Spain
Nanomaterials and Nanotechnology Research Center (CINN), Spanish National Research Council (CSIC), El Entrego, Spain
Institute of Oncology of Asturias (IUOPA), University of Oviedo, Oviedo, Spain
Health Research Institute of the Principality of Asturias (ISPA), Oviedo, Spain
Spanish Biomedical Research Network in Rare Diseases (CIBERER), Madrid, Spain
Department of Immunology and Inflammation, Imperial College London, Commonwealth Building, The Hammersmith Hospital, London, United Kingdom
Department of Biochemistry and Microbiology, University of Victoria, Victoria, BC, Canada
Cytology and Histology Unit, Department of Cell Biology, Physiology, and Immunology, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain
Nazarbayev University School of Medicine, Astana, Kazakhstan

Chromatin Biology Laboratory
Tissue Repair and Regeneration Laboratory (TR2Lab)
Nanomaterials and Nanotechnology Research Center (CINN)
Institute of Oncology of Asturias (IUOPA)
Health Research Institute of the Principality of Asturias (ISPA)
Spanish Biomedical Research Network in Rare Diseases (CIBERER)
Department of Immunology and Inflammation
Department of Biochemistry and Microbiology
Cytology and Histology Unit
Nazarbayev University School of Medicine

10 лет помогаем публиковать статьи Международный издатель

Книга Публикация научной статьи Волощук 2026 Book Publication of a scientific article 2026